PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vibrant Sciences LLC., San Carlos, CA, United States of America.\', \'Vibrant America LLC., San Carlos, CA, United States of America.\', \'Elite Medical Center, Sunnyvale, CA, United States of America.\', \'Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, NY, United States of America.\', \'Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1371/journal.pone.0242655
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 33211781
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
is ?:relation_isRelatedTo_publication of
?:title
  • Antibody profiling and prevalence in US patients during the SARS-CoV2 pandemic.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all